Get started
Award

Non Psychoactive Cannabinoids With Therapeutic Potential

Funding type: research
Funder scheme: R01
Start date: 1999-08-11
End date: 2004-06-30
Investigator: SUMNER H BURSTEIN
Institution: UNIV OF MASSACHUSETTS MED SCH WORCESTER
Funded outputs count: 9
Funder award ID: R01DA012178
OpenAlex ID: G5804395471
The cannabinoid acids, analogs and endogenous counterparts
2014 · Sumner H. Burstein · Bioorganic & Medicinal Chemistry · 23
PPAR-γ: A nuclear receptor with affinity for cannabinoids
2005 · Sumner Burstein · Life Sciences · 73
Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials
2005 · Summer Burstein · The AAPS Journal · 43
PDF
Ajulemic acid: A novel cannabinoid produces analgesia without a “high”
2004 · Sumner H Burstein, Matthias Karst, et al. · Life Sciences · 80
Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes
2003 · Bonnie Bidinger, Roxabella Torres, et al. · Clinical Immunology · 33
Suppression of human monocyte interleukin-1β production by ajulemic acid, a nonpsychoactive cannabinoid
2003 · Robert B Zurier, Ronald G Rossetti, et al. · Biochemical Pharmacology · 62
Identification of a New Class of Molecules, the Arachidonyl Amino Acids, and Characterization of One Member That Inhibits Pain
2001 · Susan M. Huang, Tiziana Bisogno, et al. · Journal of Biological Chemistry · 338
PDF
Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid 4 4Abbreviations: AJA, ajulemic acid, dimethylheptyl-THC-11-oic acid; DG, diglyceride; FBS, fetal bovine serum; MEM, Minimum Essential Medium; MTT, microculture methyl-thiazolyl tetrazolium; PKC, protein kinase C; TEM, transmission electron microscopy; TG, triglyceride; and THC, tetrahydrocannabinol.
2001 · Lawrence D. Recht, Rebecca Salmonsen, et al. · Biochemical Pharmacology · 48
Oxidative metabolism of anandamide
2000 · Sumner H Burstein, Ronald G Rossetti, et al. · Prostaglandins & Other Lipid Mediators · 145
Year
Topic